Editing Without Cutting: New Prime-Editing Strategy Writes Kilobase-Scale DNA Into the Genome
For years, the promise of precisely writing new DNA into the genome has been constrained by an awkward trade-off: the bigger the insert, the messier the edit. A study published in Nature Biotechnology now reports a way out of that bind. Researchers describe donor-complementary prime editing, or DoPE, a CRISPR-derived technique that installs DNA sequences up to 12.5 kilobases — long enough to span several small genes — into a chosen genomic address in a single step, without creating a double-strand break and without recruiting the recombinase or transposase enzymes on which most other large-insertion platforms depend. The same system, the authors show, can act as a molecular printing press: by feeding the editor a pooled library of donor DNAs built from synthesized oligonucleotides, they saturated a targeted region of a fluorescent reporter gene with mutations, and they swapped out defective exons in the disease gene PRKCSH, correcting several distinct mutations with a single, mutation-agnostic strategy.
The difficulty begins with how conventional CRISPR editing works. The canonical Cas9 nuclease cuts both strands of DNA at a targeted site, and the cell’s repair machinery then patches the wound. That repair is precise only if researchers supply a matching template and the cell uses homology-directed repair, a pathway that operates mainly in dividing cells and is notoriously inefficient. Left to its default machinery, non-homologous end joining, the cell scrambles the junction, producing unpredictable insertions and deletions. At sites cut on both strands, graver outcomes can follow: large deletions, inversions, chromosome rearrangements, and the activation of DNA-damage responses that can select against successfully edited cells. For knocking out a gene, such collateral damage is tolerable. For writing a therapeutic sequence into a defined position, it is disqualifying. Many of the most valuable edits, moreover, are large by nature: whole exons, entire genes, or regulatory modules that can span thousands of bases. Large, precise insertions have therefore been the stubborn frontier of genome editing, achievable mainly with viral vectors, transposases, or site-specific recombinases, each of which carries its own cargo limits, targeting constraints, or safety concerns.
Prime editing, first demonstrated in 2019, offered a gentler alternative. Instead of cutting both strands, a prime editor pairs a nicking form of Cas9 with an engineered reverse transcriptase. Its guide RNA, the prime editing guide RNA or pegRNA, does double duty: it locates the genomic target and carries a short RNA template that the reverse transcriptase copies directly onto the nicked strand. Because the intact complementary strand then guides repair, the method can install substitutions, small insertions, and deletions without a double-strand break. Prime editing has since proved itself for point mutations and compact edits. Writing kilobases of DNA, however, means asking the reverse transcriptase to copy enormously long RNA templates, and the efficiency of that synthesis falls steeply as templates lengthen. Larger inserts have generally demanded workarounds — twin-prime-editing schemes, integrase-based platforms, or engineered transposases — each of which adds enzymes, extra steps, or sequence constraints that limit where and how well the method works.
DoPE’s central insight is to stop asking the editor to synthesize the insert and instead let the insert deliver itself. The method couples a PE2* prime editor with a pair of overhang-complementary prime editing guide RNAs — opegRNAs — and a double-stranded DNA donor whose ends carry short 3′ single-stranded overhangs. Each opegRNA directs the editor to one side of the intended insertion site and encodes an overhang sequence complementary to one end of the donor. As the editor nicks each flanking strand and extends the exposed 3′ ends, the genome itself acquires sticky ends that mirror the donor’s. The matching sequences then anneal like two halves of a zipper, tethering the donor DNA into the gap between the two nicked sites, after which the cell’s own ligation and repair activities seal both junctions and complete the insertion. Precision comes from that complementarity: the donor anneals only where its overhangs find matching genomic sequences, so integration is guided by design rather than left to chance. Because the cargo arrives as pre-made DNA rather than being reverse-transcribed base by base, its length is limited less by the editor’s synthetic capacity than by delivery, which is why the same chemistry accommodates everything from tiny fragments to sequences longer than ten kilobases.
In the new study, the team reports precise insertions reaching 12.5 kilobases, a scale few cut-free methods achieve without enlisting integrases or transposases. Strikingly, the sticky ends that make the system work are short: overhangs of roughly 30 nucleotides proved sufficient to support the full range of inserts, from small fragments to sequences exceeding 10 kilobases. That brevity has practical consequences. The overhang is essentially the only custom sequence the platform needs, so retargeting the system or changing the cargo means redesigning two short guide RNAs and the donor ends rather than re-engineering the editor itself. One opegRNA pair, one editor, and a donor of whatever size the experiment demands — the architecture stays constant whether the cargo is a few bases or an entire gene-sized module. That plug-and-play quality is precisely the behavior that earlier insertion platforms, with their fixed recognition sites and enzyme-specific requirements, have struggled to deliver.
The same design turns out to be library-compatible, and that may prove its most consequential property. Because donors can be pooled, the researchers built collections from synthesized single-stranded oligonucleotides and used a single opegRNA pair to install a saturated library of mutations across a targeted region of EGFP, the gene for a green fluorescent reporter protein. The result was in situ saturation mutagenesis: the targeted stretch of the genome was rewritten with a comprehensive set of variants, resolvable at both amino-acid and single-nucleotide resolution, all generated inside cells in one experiment. Deep mutational scanning, the workhorse technique for measuring how thousands of protein variants behave, usually requires elaborate cloning campaigns to assemble variant libraries before they ever encounter a cell. DoPE compresses that workflow, writing the library directly into the genome in its native context, ready to be sorted and sequenced. For protein engineering, regulatory-element design, and systematic functional genomics, the method offers a route from sequence concept to cellular library without a cloning bottleneck.
The therapeutic proof of concept targeted PRKCSH, a gene whose loss-of-function mutations are linked to autosomal dominant polycystic liver disease, a condition in which fluid-filled cysts progressively enlarge the liver. Rather than correcting each patient’s mutation individually, the team used DoPE to replace mutant exons of PRKCSH — one exon at a time or two exons simultaneously — restoring the correct sequence wholesale. The strategy is mutation-agnostic: because whole exons are swapped for their healthy counterparts, any mutation lying within the replaced segment, whatever its chemical nature, is repaired by the same edit. That property addresses a persistent headache in gene therapy. Many disease genes harbor not one recurring mutation but a sprawl of rare variants scattered across the gene, and designing a bespoke editor for each is impractical. Exon-level replacement offers a single design that can cover many patients, and the study reports that distinct alleles were corrected uniformly in vitro, an early indication that the approach performs consistently across different mutant starting points.
Set against existing large-insertion tools, DoPE occupies a distinctive niche. Adeno-associated viral vectors can ferry genetic cargo but are size-restricted and integrate at random rather than chosen positions. Transposon systems move large fragments but with limited site specificity. Integrase-based platforms combine a prime editor with a serine integrase to install large sequences, and CRISPR-associated transposases target defined sites, but both recruit additional enzymes with their own sequence requirements and insertion preferences. DoPE’s parts list is minimal: one PE2* editor, two opegRNAs, and a synthetic DNA donor. No double-strand break occurs at any point, so the genotoxic hazards associated with cut-based editing — unpredictable indels at the junction, chromosomal scrambling, and DNA-damage signaling — are avoided by design rather than managed after the fact. And because targeting is written into the guide RNAs, any genomic site compatible with prime editing can in principle serve as a landing pad, keeping the method programmable in the same sense that CRISPR itself is.
The caveats are those that attend any new genome-editing platform. The results reported here were obtained in cultured cells, and performance in primary cells, tissues, and whole organisms — where delivering both a large editor and a double-stranded donor DNA is considerably harder — remains to be demonstrated. Efficiency and precision will need to be measured across many genomic contexts and cell types, and the platform’s byproduct profile, including any partial-edit intermediates or mis-annealed donors, will require systematic characterization. Off-target activity, a concern for every CRISPR-derived tool, will need dedicated assessment at scale. Independent replication across laboratories, as with any powerful new technique, will also shape how quickly the field adopts it. None of these open questions diminishes the conceptual advance; they simply mark the distance between an elegant chemistry demonstrated in vitro and a dependable research tool or therapy. The history of prime editing itself suggests a trajectory worth watching: the original system was a proof of principle in 2019 and has since been sharpened through successive rounds of protein and guide-RNA engineering.
If the method’s cell-culture performance carries forward, its implications are broad. Kilobase-scale, DSB-free, site-specific insertion without recombinases would let researchers install entire genes, swap promoters, or build synthetic regulatory circuits at defined loci, and would give gene therapy a candidate strategy for the many disorders caused by scattered mutations across large genes. The library mode, meanwhile, turns the genome itself into the substrate for high-throughput experimentation, potentially accelerating everything from enzyme evolution to the dissection of noncoding DNA elements. Genome editing began as a scalpel — a way to cut a chosen sequence and let the cell cope with the consequences. Prime editing recast it as a pencil, correcting individual letters without breaking the strand. DoPE pushes the metaphor further still: less a pencil than a compositor’s hand, setting whole paragraphs of DNA onto the genome’s page, one designed insert at a time.
Subject of Research: Development and application of donor-complementary prime editing (DoPE), a double-strand-break-free prime editing strategy enabling precise, kilobase-scale, library-compatible DNA insertion into the genome.
Subject of Research: Medicine
Article Title: Donor-complementary prime editing enables precise kilobase and library-compatible DNA insertions
Article References: Fang, Y., Tang, J., Xi, J., Yang, B., Zhang, F., & Wang, L. (2026). Donor-complementary prime editing enables precise kilobase and library-compatible DNA insertions. Nature Biotechnology. https://doi.org/10.1038/s41587-026-03296-w
Image Credits: AI Generated
DOI: 10.1038/s41587-026-03296-w
Keywords: prime editing, DoPE, genome editing, CRISPR, DNA insertion, double-strand break-free editing, saturation mutagenesis, PRKCSH, exon replacement, gene therapy
Cite Scienmag News
APA MLA Chicago
Audrey B. (August 29, 2026). Donor-matched prime editing enables precise, library-ready kilobase DNA insertions. Scienmag. https://scienmag.com/donor-matched-prime-editing-enables-precise-library-ready-kilobase-dna-insertions/
Audrey B. “Donor-matched prime editing enables precise, library-ready kilobase DNA insertions.” Scienmag, 29 August 2026, https://scienmag.com/donor-matched-prime-editing-enables-precise-library-ready-kilobase-dna-insertions/. Accessed 29 August 2026.
Audrey B. “Donor-matched prime editing enables precise, library-ready kilobase DNA insertions.” Scienmag. August 29, 2026. https://scienmag.com/donor-matched-prime-editing-enables-precise-library-ready-kilobase-dna-insertions/
Copy citation Download RIS
Tags: advanced genetic editing techniquesadvanced genome engineering methodsCRISPR-derived editing methodsCRISPR-derived gene editing techniquesdonor-complementary prime editing (DoPE)gene editinggene editing without recombinase or transposasegenome engineering without recombinase or transposasekilobase DNA insertionskilobase-scale genome editinglarge DNA insertionslarge-scale genome modificationlibrary-ready DNA insertionsmulti-gene editing with prime editingmutation correction in disease genesmutation-agnostic genome editing strategiespooled donor DNA librariesprecise DNA insertion without double-strand breaksprime editingprime editing technologysingle-step DNA integration
